Table 3.

Transfusion characteristics of TRALI Specialized Clinical Center for Outcomes Research subjects with leukemia or lymphoma

CharacteristicTRALI, n = 6Possible TRALI, n = 25TACO, n = 6Controls, n = 30
Total cases, % 7 (6/89) 19 (25/130) 7 (6/83) 18 (30/164) 
Units transfused 1 (1-1) 1 (1-2) 1 (1-2) 2.5 (2-3) 
RBCs, % 50 32 33 73 
Platelets, % 67 72 83 63 
Plasma, % 24 17 
Laboratory results     
 WBC count 1.7 (0.2-2.4) 3.1 (0.2-10.5) 3.6 (0.1-6.9) 1.6 (0.2-4.6) 
 Platelet count 24 (5-33) 25 (12-45) 43 (17-73) 22 (11-35) 
CharacteristicTRALI, n = 6Possible TRALI, n = 25TACO, n = 6Controls, n = 30
Total cases, % 7 (6/89) 19 (25/130) 7 (6/83) 18 (30/164) 
Units transfused 1 (1-1) 1 (1-2) 1 (1-2) 2.5 (2-3) 
RBCs, % 50 32 33 73 
Platelets, % 67 72 83 63 
Plasma, % 24 17 
Laboratory results     
 WBC count 1.7 (0.2-2.4) 3.1 (0.2-10.5) 3.6 (0.1-6.9) 1.6 (0.2-4.6) 
 Platelet count 24 (5-33) 25 (12-45) 43 (17-73) 22 (11-35) 

Subjects are from the TRALI Specialized Clinical Center for Outcomes Research study. Data are reported as median values (interquartile ranges) or numbers (percentages). WBC, white blood cell.